APA (7th ed.) Citation

Yu, T., Cao, J., Alaa Eddine, M., Moustafa, M., Mock, A., Erkut, C., . . . Jungwirth, G. (2021). Receptor-tyrosine kinase inhibitor ponatinib inhibits meningioma growth in vitro and in vivo. Cancers, 13(23), . https://doi.org/10.3390/cancers13235898

Chicago Style (17th ed.) Citation

Yu, Tao, et al. "Receptor-tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth in Vitro and in Vivo." Cancers 13, no. 23 (2021). https://doi.org/10.3390/cancers13235898.

MLA (9th ed.) Citation

Yu, Tao, et al. "Receptor-tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth in Vitro and in Vivo." Cancers, vol. 13, no. 23, 2021, https://doi.org/10.3390/cancers13235898.